Amicus Therapeutics (FOLD) Reports Preliminary 2021 Revenue, Provides 2022 Strategic Outlook and Revenue Guidance
Go back to Amicus Therapeutics (FOLD) Reports Preliminary 2021 Revenue, Provides 2022 Strategic Outlook and Revenue Guidance| Amicus Therapeutics, Inc. (NASDAQ: FOLD) | Delayed: 10.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.54 | 52 Week High | $11.78 | |||
| Open | $10.54 | 52 Week Low | $4.98 | |||
| Day High | $10.54 | P/E | N/A | |||
| Day Low | $10.54 | EPS | $-1.15 | |||
| Volume | 2,873 | |||||
